Abstract | AIMS: MAIN METHODS: KEY FINDINGS:
Schizandrin inhibited the production and mRNA expression of TSLP in HMC-1 cells. The maximal inhibition rate of TSLP production by schizandrin (10 μM) was 68.62 ± 3.47%. Schizandrin inhibited the translocation and luciferase activity of nuclear factor-κB induced by phorbol myristate acetate plus A23187. In the activated HMC-1 cells, the activation of caspase-1 was increased, whereas the activation of caspase-1 was decreased by pretreatment with schizandrin. SIGNIFICANCE: These results suggest that schizandrin can be used to treat inflammatory and atopic diseases through the inhibition of TSLP.
|
Authors | Phil-Dong Moon, Hyun-Ja Jeong, Hyung-Min Kim |
Journal | Life sciences
(Life Sci)
Vol. 91
Issue 11-12
Pg. 384-388
(Oct 05 2012)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 22906632
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Inc. All rights reserved. |
Chemical References |
- Cyclooctanes
- Cytokines
- Lignans
- Polycyclic Compounds
- Calcimycin
- Luciferases
- Caspase 1
- schizandrin
- Tetradecanoylphorbol Acetate
- Thymic Stromal Lymphopoietin
|
Topics |
- Blotting, Western
- Calcimycin
(pharmacology)
- Caspase 1
(biosynthesis)
- Cell Line
- Cyclooctanes
(pharmacology)
- Cytokines
(biosynthesis)
- Enzyme-Linked Immunosorbent Assay
- Humans
- Lignans
(pharmacology)
- Luciferases
- Mast Cells
(drug effects, metabolism, physiology)
- Polycyclic Compounds
(pharmacology)
- Reverse Transcriptase Polymerase Chain Reaction
- Tetradecanoylphorbol Acetate
(pharmacology)
- Thymic Stromal Lymphopoietin
|